IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

IMCAS World Congress 2020
Program

FOCUS ON S336

Young surgeons' awards

Focus program

Room: Room 351 - level 3
Date: Saturday 1 February 2020 at 17:30 to 18:30
Format: CONTEST > competition in front of a high-profile jury to present and pitch groundbreaking projects and/or research

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
17:30	Dr Flore DELAUNAY	Jury		97751
17:30	Dr Jonathan FERNANDEZ	Jury		97752
17:30	Dr Eva BRULOY	Botulinum toxin versus a placebo: a meta-analysis on the prophylactic treatment of migraine	View	99634
17:40	Dr Rumi KISYOVA	Vascularised composite autotransplantation		94364
17:50	Dr Romain LAURENT	Rupture, capsular retraction, ALCL, precautionary principle… When should we change the implants?		100649
18:00	Dr Flore DELAUNAY	Young surgeons award winner announced by jury		94370

Go to previous session

Go to next room (Room 352 - level 3)

Recommended sessions

Botulinum toxins

Dr Flore DELAUNAY

Plastic Surgeon

France

Other author(s) :

Jury

Dr Jonathan FERNANDEZ

Plastic Surgeon

France

Other author(s) :

Jury

Dr Eva BRULOY

Plastic Surgeon

France

Other author(s) : R Sinna, B Chaput

Botulinum toxin versus a placebo: a meta-analysis on the prophylactic treatment of migraine

Objectives: The purpose of this study was to assess the efficacy of botulinum toxin in reducing the frequency of migraine headaches.

Introduction: The literature provides contradictory results on the efficacy of this treatment. Thus, the objective of this metaanalysis, which includes double-blind randomized clinical trials, was to assess the effectiveness of botulinum toxin type A injections on changes in the frequency of migraines, its impact on the quality of life, but also its safety versus placebo when injected into pericranial muscles as a preventive treatment for migraines in adults.

Materials / method: The MEDLINE, Embase, and Cochrane Library databases were searched to identify randomized, double-blind, placebo-controlled trials that compared patients receiving botulinum toxin versus placebo injections in the head and neck muscles, for the preventive treatment of migraine. The primary outcome was change in the number of headache episodes per month from baseline to 3 months.

Results: There were 17 studies including a total of 3646 patients. Overall analysis reported a tendency in favor of botulinum toxin over placebo at 3 months, with a difference in the change of migraine frequency of -0.23 (95 percent CI, -0.47 to 0.02; p = 0.08). The reduction in frequency of chronic migraines was significant, with a mean differential change of -1.56 (95 percent CI, -3.05 to -0.07; p = 0.04). Analysis of chronic migraine frequency was also significant after 2 months. The findings also highlighted an improvement of the patient's quality of life at 3 months in the botulinum toxin group.

Conclusion: This meta-analysis reveals that botulinum toxin type A injections are superior to placebo for chronic migraines after 3 months of therapy. For the first time, a real benefit in patient quality of life is demonstrated with only few and mild adverse events.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Rumi KISYOVA

Plastic Surgeon

United Kingdom

Other author(s) : R.Kisyova1, E,Pescarini1,2, B.Bisase3, P.Norris3, C.Nduka1, J.Dhanda3, I.Koshima4, R.Y.Kannan1 1Facial Palsy Unit, Queen Victoria Hospital, East Grinstead, UK. 2Dept. of Plastic Surgery, University of Padova, Italy. 3Dept. of Maxillofacial Surgery, Queen

Vascularised composite autotransplantation

Objectives: The aim of a good plastic surgery reconstruction is to cover the defect, support the surrounding tissues, restore the volume and the neurology of the affected area1. Nowadays limb and face transplants are becoming more and more popular, and when applied onto a well selected patient, they show good functional outcomes. However, this procedures are associated with high systemic complication rates related to the lifelong immunosuppression therapy following a these complex procedures. The use of Vascullarised Composite Autotransplants (VCAT) also known as Chimeric Functional flaps2,3 is an excell

Conclusion: References:
1. Kannan, R. The Plastic Surgery Pyramid: redefining the yardsticks, Plastic and Reconstructive Surgery 2014 May;133(5): 733e-734e
2. Hallock G. Simultaneous Transposition of anterior Thigh Muscle and Fascia Flaps: An introduction of the Chimera Flap Principle, Annals of Plastic Surgery, Vol 27, No 2, August 1991
3. Kofi O. Boahene et al The Multivector Gracilis Free Functional Muscle Flap for Facial Reanimation, JAMA Facial Plastic Surgery

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Romain LAURENT

Plastic Surgeon

France

Other author(s) : E. BRULOY, P-A GIROUX, R. CHARTIER, N. ASSAF, R. SINNA

Rupture, capsular retraction, ALCL, precautionary principle… When should we change the implants?

Introduction: Prosthetic breast augmentation remains one of the most aesthetic surgery performed worldwide. Breast implants benefited from fabrication and conception improvements since their creation such as the multi-layer shell or the high-cohesive gel. However, patients are still exposed to complications of rupture, capsular retraction and anaplasic large cell lymphoma.
The objective of this presentation is to appreciate the optimal time to change the implants.
The decision to change depends on several factors: the occurrence of complications, the surgeon's experience, the patient and the data in the literature. Although the new generations of breast implants are more resistant with an extended lifespan, it would be wise not to leave them in place for a prolonged period of time because of the evolutionary risks inherent in the implants. We propose a diagram regarding the surveillance of breast implants as well as a decisional algorithm for their replacements.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Flore DELAUNAY

Plastic Surgeon

France

Other author(s) :

Young surgeons award winner announced by jury

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS World Congress 2020 Program

FOCUS ON S336

Young surgeons' awards

Lectures of the session

Recommended sessions

IMCAS World Congress 2020
Program